Greater Cannabis Company (GCAN) Return on Capital Employed Growth (1y) (2019 - 2026)
Greater Cannabis Company (GCAN) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.45 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,195.00 |
| 10 | Greater Cannabis Company | 236,233.75 | 234,794.75 | - | 549.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 549.00 |
| Dec 31, 2025 | 636.00 |
| Sep 30, 2025 | -558.00 |
| Jun 30, 2025 | -781.00 |
| Mar 31, 2025 | -866.00 |
| Dec 31, 2024 | -855.00 |
| Sep 30, 2024 | -693.00 |
| Jun 30, 2024 | -371.00 |
| Mar 31, 2024 | -464.00 |
| Dec 31, 2023 | -589.00 |
| Sep 30, 2023 | -1,877.00 |
| Jun 30, 2023 | -1,817.00 |
| Mar 31, 2023 | -1,887.00 |
| Dec 31, 2022 | -5,045.00 |
| Sep 30, 2022 | -7,092.00 |
| Jun 30, 2022 | -9,665.00 |
| Mar 31, 2022 | -1,675.00 |
| Dec 31, 2021 | -3,061.00 |
| Sep 30, 2021 | 5,281.00 |
| Jun 30, 2021 | 9,813.00 |